Osteoporosis in inflammatory joint diseases

被引:125
|
作者
Roux, C. [1 ]
机构
[1] Paris Descartes Univ, Cochin Hosp, Dept Rheumatol, Paris, France
关键词
Ankylosing spondylitis; Bone formation; Bone resorption; Osteoporosis; Rheumatoid arthritis; Vertebral fracture; BONE-MINERAL DENSITY; EARLY RHEUMATOID-ARTHRITIS; NECROSIS-FACTOR-ALPHA; EARLY ANKYLOSING-SPONDYLITIS; POPULATION-BASED CONTROLS; X-RAY ABSORPTIOMETRY; VERTEBRAL FRACTURES; BODY-COMPOSITION; TNF-ALPHA; POSTMENOPAUSAL WOMEN;
D O I
10.1007/s00198-010-1319-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rheumatoid arthritis (RA) and ankylosing spondylitis (AS) are two inflammatory joint diseases characterized by bone complications including osteoporosis. In RA, periarticular bone loss, bone erosions, and systemic osteoporosis are observed, with an increased risk of fractures. Determinants of fractures are underlying conditions (as RA has a female preponderance and an increased prevalence with age), severity of the disease, and use of glucocorticoids. However, bone loss can occur even in glucocorticoid-naive patients. Prospective data show that the optimal control of inflammation in RA is associated with decrease in structural damage and bone loss. RA illustrates the role of inflammation on bone resorption. In AS, osteoporosis is an early event and vertebral fracture risk is increased. Bone loss is related mainly to inflammation, as the disease can occur in young male adult populations, and glucocorticoids are not used in this disease. However, AS is characterized by progressive stiffness and ankylosis of the spine and illustrates also the potential role of inflammation on local bone formation.
引用
收藏
页码:421 / 433
页数:13
相关论文
共 50 条
  • [41] The temporomandibular joint and inflammatory rheumatic diseases
    Marotte, H.
    REVUE DE STOMATOLOGIE DE CHIRURGIE MAXILLO-FACIALE ET DE CHIRURGIE ORALE, 2016, 117 (04) : 223 - 227
  • [42] Hydrogen Sulfide and Inflammatory Joint Diseases
    Burguera, Elena F.
    Meijide-Failde, Rosa
    Blanco, Francisco J.
    CURRENT DRUG TARGETS, 2017, 18 (14) : 1641 - 1652
  • [43] THERAPY OF INFLAMMATORY AND DEGENERATIVE JOINT DISEASES
    CHLUD, K
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 1980, 130 : 12 - 27
  • [44] Shoulder Involvement in Inflammatory Joint Diseases
    Seidel, W.
    Scholz, R.
    AKTUELLE RHEUMATOLOGIE, 2011, 36 (02) : 103 - 105
  • [45] Pathophysiology of drug-induced osteoporosis and osteoporosis in inflammatory systemic rheumatic diseases
    Patschan, D
    Buttgereit, F
    AKTUELLE RHEUMATOLOGIE, 2001, 26 (03) : 95 - 100
  • [46] Nutrients in the Prevention of Osteoporosis in Patients with Inflammatory Bowel Diseases
    Ratajczak, Alicja Ewa
    Rychter, Anna Maria
    Zawada, Agnieszka
    Dobrowolska, Agnieszka
    Krela-Kazmierczak, Iwona
    NUTRIENTS, 2020, 12 (06)
  • [47] COMPLEX THERAPY OF SECONDARY OSTEOPOROSIS IN INFLAMMATORY RHEUMATIC DISEASES
    Nemes, D.
    Nemes, C.
    Dragoi, M.
    Poenaru, D.
    Cretu, O.
    Surducan, D.
    Popa, D.
    Dragoi, R.
    Suciu, O.
    Andrei, D.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 : 60 - 61
  • [48] Angiogenesis in the pathogenesis of inflammatory joint and lung diseases
    Walsh, DA
    Pearson, CI
    ARTHRITIS RESEARCH, 2001, 3 (03) : 147 - 153
  • [49] Sex and Cardiovascular Involvement in Inflammatory Joint Diseases
    Santos Castañeda
    Carlos González-Juanatey
    Miguel A. González-Gay
    Clinical Reviews in Allergy & Immunology, 2019, 56 : 278 - 292
  • [50] Frontiers in inflammatory joint diseases conference - Introduction
    Inman, RD
    El-Gabalawy, HS
    JOURNAL OF RHEUMATOLOGY, 2005, 32 : 1 - 2